enVVeno Medical (NVNO) Competitors $0.92 -0.04 (-4.17%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$0.92 0.00 (-0.04%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. ICCM, QTI, LUNG, DXR, TELA, SURG, CTSO, MDAI, PYPD, and SRTSShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include IceCure Medical (ICCM), QT Imaging (QTI), Pulmonx (LUNG), Daxor (DXR), TELA Bio (TELA), SurgePays (SURG), Cytosorbents (CTSO), Spectral AI (MDAI), PolyPid (PYPD), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. enVVeno Medical vs. Its Competitors IceCure Medical QT Imaging Pulmonx Daxor TELA Bio SurgePays Cytosorbents Spectral AI PolyPid Sensus Healthcare enVVeno Medical (NASDAQ:NVNO) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Do insiders and institutionals hold more shares of NVNO or ICCM? 34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 16.0% of enVVeno Medical shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend NVNO or ICCM? IceCure Medical has a consensus target price of $2.64, suggesting a potential upside of 173.26%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60 Which has better earnings & valuation, NVNO or ICCM? IceCure Medical has higher revenue and earnings than enVVeno Medical. IceCure Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$21.82M-$1.20-0.76IceCure Medical$3.29M20.14-$15.32M-$0.16-6.03 Does the media favor NVNO or ICCM? In the previous week, IceCure Medical had 14 more articles in the media than enVVeno Medical. MarketBeat recorded 18 mentions for IceCure Medical and 4 mentions for enVVeno Medical. IceCure Medical's average media sentiment score of 0.53 beat enVVeno Medical's score of 0.38 indicating that IceCure Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment enVVeno Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IceCure Medical 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Is NVNO or ICCM more profitable? enVVeno Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -317.62%. enVVeno Medical's return on equity of -57.35% beat IceCure Medical's return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -57.35% -53.49% IceCure Medical -317.62%-136.96%-71.46% Which has more volatility and risk, NVNO or ICCM? enVVeno Medical has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. SummaryIceCure Medical beats enVVeno Medical on 9 of the 16 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.43M$7.12B$6.14B$10.64BDividend YieldN/A1.16%5.66%4.69%P/E Ratio-0.7627.4685.7227.64Price / SalesN/A192.73631.45142.60Price / CashN/A22.0838.3262.20Price / Book0.385.3513.096.79Net Income-$21.82M$178.04M$3.30B$275.88M7 Day Performance-5.23%2.21%3.75%1.84%1 Month Performance27.43%13.46%10.73%8.84%1 Year Performance-70.60%31.89%85.28%36.10% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical1.01 of 5 stars$0.92-4.2%N/A-69.9%$18.43MN/A-0.7630News CoverageAnalyst ForecastGap DownICCMIceCure Medical3.1005 of 5 stars$1.02-0.5%$2.39+135.0%+66.3%$70.07M$3.29M0.0060Analyst ForecastAnalyst RevisionQTIQT ImagingN/A$2.50-2.0%N/A+289.8%$67.84M$4.00M0.00N/APositive NewsGap DownLUNGPulmonx3.4273 of 5 stars$1.62-1.8%$7.66+373.1%-74.6%$67.23M$83.79M-1.13250News CoverageAnalyst ForecastDXRDaxor3.8048 of 5 stars$13.77+6.3%$25.00+81.6%+39.0%$62.69MN/A0.0037Analyst ForecastGap UpHigh Trading VolumeTELATELA Bio2.3677 of 5 stars$1.49-0.7%$4.50+202.0%-39.1%$59.42M$69.30M-1.33120News CoverageAnalyst ForecastSURGSurgePays3.1439 of 5 stars$2.81-1.7%$9.00+220.3%+59.5%$58.43M$60.88M-1.1340News CoverageAnalyst ForecastCTSOCytosorbents2 of 5 stars$0.93+0.9%$5.50+488.8%-17.5%$58.08M$35.60M-5.49220Positive NewsGap DownMDAISpectral AI2.9838 of 5 stars$2.28+6.0%$3.50+53.5%+120.7%$57.47M$29.58M-3.3083News CoveragePositive NewsAnalyst ForecastGap UpPYPDPolyPid3.1449 of 5 stars$3.34+0.3%$12.40+271.3%-7.8%$52.94MN/A-0.8780News CoverageAnalyst ForecastShort Interest ↑SRTSSensus Healthcare2.807 of 5 stars$3.14-0.9%$8.00+154.8%-46.2%$52.12M$41.81M-52.3340Analyst Forecast Related Companies and Tools Related Companies ICCM Alternatives QTI Alternatives LUNG Alternatives DXR Alternatives TELA Alternatives SURG Alternatives CTSO Alternatives MDAI Alternatives PYPD Alternatives SRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon callingElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
